Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Part of paid clinical trials in Miami, Florida.

Sponsor
University of Miami
Study ID
NCT06730555
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • ACCESS Intervention — BEHAVIORAL
    Participants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.
  • Control Group — BEHAVIORAL
    Participants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.

Study Details

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Key Dates

Start date
Jun 27, 2025
Status verified
Sep 2025
Primary completion
Aug 1, 2028
Completion
Aug 1, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Experimental: ACCESS Group
    Participants in this group will receive the ACCESS intervention for up to 18 months
  • Active Comparator: Control Group
    Participants in this group will receive a link to the CDC Compendium of Evidence-Based Interventions for up to 18 months.

Primary Outcome Measure

Number of SSP participants reached [ Time Frame: up to 18 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MiamiMiamiFlorida33136
Tyler Bartholomew, PhD
3056897030
Hansel Tookes, MD (PRINCIPAL_INVESTIGATOR)
Tyler Bartholomew, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

By condition
By specialty

Related Studies